Lupin FY 05 Net Sales up 4% at Rs. 11,611 mn
20 May 2005

Lupin Pharmaceuticals, Inc. and Cornerstone BioPharma, Inc.Enter Co-Promotion Agreement for Suprax®
27 Jan 2005

Lupin Net Sales up 10% at Rs. 2,796 mn
25 Jan 2005

Lupin cranks up the R&D Engine
27 Oct 2004

Lupin Limited today announced that it plans to triple its spend on Research from Rs. 400 million in FY 2003-04 to Rs. 1.20 billion in FY 2004-05.
29 Jul 2004

Lupin and Ind-Swift launch new anti-diarrhoeal drug
9 Jun 2004

Lupin FY 2003-04 revenue up 22% at Rs 12.3 billion
28 Apr 2004

Lupin receives INDA approval for psoriasis oral treatment
22 Apr 2004

Lupin Launches Branded Finished Dosage in the US Sets up Pediatric Sales Force
06 Apr 2004

Lupin Enters into Collaboration to Promote Zymar to Pediatricians in the U.S.
29 Mar 2004

Lupin's non-cephalosporin oral finished dosage facility at Goa goes on stream
26 Mar 2004

Lupin launches Herbal Business
22 Mar 2004

Lupin enters into an alliance with Baxter for Ceftriaxone
28 Feb 2004

Lupin receives USFDA approval for Cefixime Suspension
24 Feb 2004

Lupin receives USFDA approval for Cefixime Tablets
13 Feb 2004

Lupin Net Profit up 77% at Rs. 400 mn; Net Sales up 10% at Rs. 2629 mn;Debt Equity Ratio improves to 0.85:1
20 Jan 2004

Lupin appoints new President for Asia Pacific,Latin America
08 Jan 2004

Lupin launches novel cholesterol-fighter EZEDOC
02 Jan 2004

Lupin files INDA for anti-psoriasis
31 Dec 2003

Lupin receives IND approval for anti-migraine molecule
05 Dec 2003

Two Citigroup representatives join Lupin’s board
05 Dec 2003

Promoters sell 4% of Lupin equity
04 Nov 2003

Lupin promoters, Newbridge call off discussions
13 Oct 2003

Lupin promoters place 12.55% equity with CVC International
11 Oct 2003

Lupin Q2 FY 2003-04 net profit before extraordinary items at Rs.518 million,up 86%; sales up 36% at Rs 3609 million
10 Oct 2003

Lupin receives USFDA approval for ceftriaxone sterile vials for injection
01 Oct 2003

Lupin receives USFDA approval for cefotaxime sterile vials for injection
25 Sep 2003

Dr. Kamal K. Sharma to join Lupin as Managing Director
25 Aug 2003

Lupin Q1 FY 2003-04 net profit up 38% at Rs 280.6 million; sales up 23% at Rs 2,769 million
31 Jul 2003

Lupin receives USFDA approval for cefuroxime axetil tablets
28 Jul 2003

Lupin FY2002-03 net sales up 19% at Rs 10.3 billion
20 May 2003

Lupin launches once-a-day dosage cephalexin
09 May 2003

Statement on media reports linking SARS outbreak with demand for Lupin's ribavirin
17 Apr 2003

Lupin files ANDAs for Ceftriaxone and Cefotaxime
16 Apr 2003

Lupin to set up new Lovastatin plant A move to consolidate presence in lifestyle drugs
13 Feb 2003

Lupin Q3 sales up 19% at Rs. 2868 mn; net profit up 23% at Rs. 227mn
28 Jan 2003

Lupin Q2 sales up 23% at Rs. 2,985 mn; profit before tax up 35% at Rs. 353 mn
29 Oct 2002

Lupin Q1 FY03 sales at Rs 2514 million, up 8%; net up 26% at Rs 203 million
24 Jul 2002